ACTIVITY IN 2016

(Unaudited data)

thousands of euros
2015
2016
Variation at current exchange rates
Variation at constant exchange rates


France
361,765
370,870
+2.5%
+2.5%


Europe (excluding France)
167,714
163,849
-2.3%
-0.3%


North America
63,858
64,916
+1.7%
+1.9%


Other countries
14,466
14,854
+2.7%
+3.7%


Group total
607,803
614,489
+1.1%
+1.7%

thousands of euros
2015
2016
Variation at current exchange rates
Variation at constant exchange rates


Non-proprietary Homeopathic Medicines
310,555
313,365
+0.9%
+0.9%


OTC Specialties
296,954
299,672
+0.9%
+2.1%


Other
294
1,452
+393.9%
+393.9%


Group total
607,803
614,489
+1.1%
+1.7%

thousands of euros
1st quarter
2nd quarter
3rd quarter
4th quarter


2015
2016
Var.

16/15
2015
2016
Var. 16/15
2015
2016
Var.

16/15
2015
2016
Var.

16/15


France
89,584
90,494
+1.0%
76,864
80,469
+4.7%
97,767
98,840
+1.1%
97,550
101,067
+3.6%


Europe (excluding France)
40,657
43,685
+7.4%
29,943
31,572
+5.4%
50,614
41,273
-18.5%
46,500
47,319
+1.8%


North America
17,193
16,064
-6.6%
12,894
14,113
+9.5%
16,055
16,020
-0.2%
17,716
18,719
+5.7%


Other countries
4,622
3,846
-16.8%
3,816
4,061
+6.4%
3,594
3,280
-8.7%
2,434
3,667
+50.7%


Group total
152,056
154,089
+1.3%
123,517
130,215
+5.4%
168,030
159,413
-5.1%
164,200
170,772
+4.0%

thousands of euros
1st quarter
2nd quarter
3rd quarter
4th quarter


2015
2016
Var.

16/15
2015
2016
Var.

16/15
2015
2016
Var.

16/15
2015
2016
Var.

16/15


Non-proprietary Homeopathic Medicines
79,191
80,147
+1.2%
74,354
76,001
+2.2%
73,677
73,913
+0.3%
83,333
83,304
-0.0%


OTC Specialties
72,880
73,743
+1.2%
49,030
53,719
+9.6%
94,328
85,319
-9.6%
80,716
86,891
+7.7%


Other
-15
199
-
133
495
+272.2%
25
181
+624.0%
151
577
+282.1%


Group total
152,056
154,089
+1.3%
123,517
130,215
+5.4%
168,030
159,413
-5.1%
164,200
170,772
+4.0%

HIGHLIGHTS OF THE FOURTH QUARTER

Sales revenue in the fourth quarter 2016 grew by 4% (+3.7% at constant rate). This growth is linked to the context of flu pathology at the end of the year.

Annual sales revenue amounted €614,489 thousand, in increase by 1.1% against 2015 (+1.7% at constant rate). Thus, the 2016 operating income will be slightly higher than in 2015.

On December 14, 2016, a project of new organization of the establishments in France has been presented to the Central Works Committee. The consultation with the social partners will continue until March 2017.

Our next update: March 15, 2017, after the close of the stock market, publication of 2016 results.

Person responsible for financial information: Christian Boiron

Contact for financial information: Véronique Bouscayrol

Investor relations: +33 (0) 4.78.45.63.43 - e-mail : boironfinances@boiron.fr

ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA

The group's financial information is online at: www.boironfinance.com

Source: Actusnews